Zurita-Cruz JN

Language: Spanish
References: 11
Page: 165-167
PDF size: 290.16 Kb.

REFERENCES

1. Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025; 13(3): 221-262. Erratum in: Lancet Diabetes Endocrinol. 2025; 13(3): e6. doi: 10.1016/S2213-8587(25)00006-3.

2. Organización Mundial de la Salud. Obesidad y sobrepeso [Internet]. Ginebra: OMS; 2024 [Citado 20 Jun 2024]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight

3. Shamah-Levy T, Gaona-Pineda EB, Cuevas-Nasu L, et al. Sobrepeso y obesidad en población escolar y adolescente. Salud Publica Mex. 2024; 66: 404-413.

4. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1223-1249. doi: 10.1016/S0140-6736(20)30752-2.

5. Zaccagni L, Gualdi-Russo E. Reduced physical activity and increased weight status in children and adolescents during the COVID-19 pandemic: a systematic review. Children (Basel). 2025; 12(2): 178. doi: 10.3390/children12020178.

6. Nylander C, Nowicka P, Derwig M. The prevalence of overweight among 4-year-olds during and after the COVID-19 pandemic was associated with socioeconomic burden. Acta Paediatr. 2025; 114(3): 555-561. doi: 10.1111/apa.17468.

7. Lugowska K, Krzecio-Nieczyporuk E, Trafialek J, Kolanowski W. Changes in BMI and fat mass and nutritional behaviors in children between 10 and 14 years of age. Nutrients. 2025; 17(7): 1264. doi: 10.3390/nu17071264.

8. Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB. SARS-CoV-2 Infection and new-onset type 2 diabetes among pediatric patients, 2020 to 2022. JAMA Netw Open. 2024; 7(10): e2439444. doi: 10.1001/jamanetworkopen.2024.39444.

9. Lee DH, Kim HY, Park JY, Kim J, Park JH. New-onset type 1 and type 2 diabetes among Korean youths during the COVID-19 pandemic. JAMA Pediatr. 2025; 179(2): 155-162. doi: 10.1001/jamapediatrics.2024.5068.

10. Gündüz BO, Camurdan AD, Yildiz M, Aksakal FNB, Ünsal EN. The impact of COVID-19 pandemic on sarcopenic obesity among children between 6 and 10 years of age: a prospective study. Eur J Pediatr. 2025; 184(4): 251. doi: 10.1007/s00431-025-06067-y.

11. Villasís-Keever MA, Zurita-Cruz J. El papel de los pediatras en el manejo de niños y adolescentes con sobrepeso u obesidad. Rev Mex Pediatr. 2023; 90 (S1): s4-9. doi: 10.35366/115874.